ivWatch aims to reduce patient harm related to IV infiltration and extravasation through the use of continuous IV monitoring.
IvWatch, LLC: Revolutionizing Patient Care with Continuous IV Monitoring
IvWatch, LLC is a medical technology company that has been at the forefront of developing innovative solutions to reduce patient harm related to IV infiltration and extravasation. The company's mission is to improve patient outcomes by providing healthcare professionals with real-time information about the status of intravenous (IV) therapy.
Intravenous therapy is a common medical procedure used to deliver fluids, medications, and nutrients directly into a patient's bloodstream. However, it can also lead to complications such as infiltration and extravasation. Infiltration occurs when the IV fluid leaks into surrounding tissue instead of entering the vein. Extravasation occurs when medication or other substances leak into surrounding tissue causing damage.
These complications can cause pain, swelling, tissue damage, and even necrosis in severe cases. They can also lead to longer hospital stays and increased healthcare costs for patients.
To address these issues, IvWatch has developed an innovative solution that uses continuous monitoring technology to detect early signs of infiltration or extravasation before they become serious problems. The device uses optical sensors that are placed on the skin near the IV site to monitor changes in tissue composition caused by fluid leakage.
The system provides real-time alerts when there are changes in fluid levels around the IV site so that healthcare professionals can take immediate action before any harm occurs. This allows for early intervention which reduces pain and discomfort for patients while improving their overall outcomes.
The IvWatch system has been clinically validated through multiple studies demonstrating its effectiveness in reducing patient harm related to IV therapy complications. It has received FDA clearance for use in adults and children over 2 years old.
In addition to its clinical benefits, IvWatch's continuous monitoring technology also offers significant cost savings for hospitals by reducing treatment costs associated with complications from infiltrations or extravasations.
IvWatch was founded in 2010 by Gary Warren who experienced firsthand how devastating an infiltration injury could be after his wife suffered one during her hospital stay. He recognized the need for better solutions and set out on a mission to develop a device that would prevent others from experiencing similar injuries.
Since then IvWatch has grown significantly with offices located across North America including Virginia Beach (VA), Toronto (ON), San Diego (CA), Minneapolis (MN) & London(UK). The company continues its commitment towards innovation & research aimed at improving patient care worldwide through continuous monitoring technologies like ivNowโข -a wearable sensor designed specifically for home infusion patients- which will be launched soon!
In conclusion,
IvWatch is revolutionizing patient care through its innovative approach towards reducing harm related to intravenous therapy procedures using continuous monitoring technologies like ivNowโข & ivSafeโข(an automated documentation system). With FDA clearance already obtained & multiple clinical validations under their belt; this Virginia-based medtech firm looks poised not only make waves within US but globally too!